Stakeholder Interaction​

Identifying stakeholders and recognizing material issues are core elements in realizing corporate sustainability. OBI Pharma refers to the AA1000 SES Stakeholder Engagement Standard, categorizing key stakeholders based on factors such as dependency, responsibility, influence, diverse perspectives, and tension of concern.
The primary stakeholders identified include eight groups: Shareholders/Investors/Brokers, Government Agencies, Suppliers, Employees, Medical Institutions (Healthcare Professionals), Industry Associations, Academic and Research Institutions, and Banks.
Following the principles of completeness, responsiveness, and inclusiveness, the sustainability project team has identified nine material topics, ranked as follows: Product Research and Innovation, Clinical Trials and Subsequent Development, Intellectual Property Protection, Information Disclosure, Economic Performance, Customer Health and Safety, Occupational Safety and Health, Labor-Management Relations, and Training and Education.​

The company has established a diverse range of mechanisms for interacting and communicating with stakeholders, utilizing various channels to understand their expectations and concerns regarding the company's sustainable development. In response, the company not only addresses these concerns promptly but also incorporates them into its corporate sustainability development plans. OBI Pharma's Sustainability Development Executive Committee holds annual internal meetings to identify and analyze sustainability topics. The conclusions from stakeholder engagements and the company's sustainability achievements are disclosed in the OBI Pharma Sustainability Report, which is submitted to the Board of Directors for guidance and review.